Select Medical Holdings (SEM) Capital Expenditures (2018 - 2026)

Select Medical Holdings has disclosed Capital Expenditures across 9 years of filings, most recently posting $58.9 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 12.53% year-over-year to $58.9 million; the TTM figure through Mar 2026 stood at $235.8 million (up 991.29% YoY), while the FY2025 annual figure was $229.2 million, up 952.26% from the prior year.
• Capital Expenditures steadied at $58.9 million in Q1 2026, from $59.1 million in the prior quarter.
• Over the last five years, Capital Expenditures for SEM reached as high as $64.7 million in Q2 2025 and fell as low as -$137.0 million in Q4 2024.
• The 5-year median for Capital Expenditures is $53.1 million (2025), against an average of $42.9 million.
• Annual changes were most pronounced in 2024 — Capital Expenditures tumbled 326.0% — and 2025, when it surged 143.15%.
• A 5-year view of Capital Expenditures shows it stood at $55.3 million in 2022, then increased by 9.68% to $60.6 million in 2023, then plunged by 326.0% to -$137.0 million in 2024, then surged by 143.15% to $59.1 million in 2025, then dropped by 0.34% to $58.9 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $58.9 million, $59.1 million, and $53.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.